Metal Ion Concentrations After Total Knee Arthroplasty
Launched by MAYO CLINIC · Jun 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the levels of metal ions in the blood of patients after they have undergone total knee replacement surgery. There are two types of surgeries being compared: one that uses advanced robotic assistance and another that uses traditional cutting guides. The goal is to see how these different methods affect the amount of metal in the bloodstream after surgery.
To participate in this study, you need to be an adult who is planning to have either type of knee surgery and willing to give your consent to join the trial. However, if you have had any previous knee surgeries, have metal implants from past injuries, or weigh less than 110 pounds, you won't be eligible. If you join, you can expect to have your blood tested for metal levels at certain points after your surgery, which will help researchers understand the effects of these different surgical approaches. This trial is currently looking for participants, so if you meet the criteria and are interested, you might want to consider joining.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults undergoing conventional or robotic-assisted TKA
- • Consent to the study
- Exclusion Criteria:
- • Patients who have undergone any previous arthroplasty procedures.
- • Patients with metal implants, such as plates, nails, and screws, used in the repair of traumatic injuries.
- • Patients below 110 pounds.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Matthew P Abdel
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported